Cyclodextrins inhibit replication of scrapie prion protein in cell culture

Journal of Virology

Volumn 81, Issue 20, 2007, Pages 11195-11207

  Prior, Marguerite ^a   Lehmann, Sylvain ^b   Sy, Man Sun ^c   Molloy, Brendan ^a   McMahon, Hilary E M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b INSTITUTE OF HUMAN GENETICS   (France)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; CYCLODEXTRIN; PRION PROTEIN;

ARTICLE; CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENCAPSULATION; HYDROPHOBICITY; IC 50; NEUROBLASTOMA CELL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; SCRAPIE AGENT; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ALPHA-CYCLODEXTRINS; ANIMALS; BETA-CYCLODEXTRINS; CELL LINE, TUMOR; CYCLODEXTRINS; INHIBITORY CONCENTRATION 50; MICE; NEUROBLASTOMA; PRION DISEASES; PRPSC PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

SCRAPIE PRION;

EID: 35148878615     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02559-06     Document Type: Article

References (68)

1. Abulrob, A., J. S. Tauskela, G. Mealing, E. Brunette, K. Faid, and D. Stanimirovic. 2005. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. J. Neurochem. 92:1477-1486.
2. Adjou, K. T., R. Demaimay, J. P. Deslys, C. I. Lasmezas, V. Beringue, S. Demart, F. Lamoury, M. Seman, and D. Dormont. 1999. MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie. J. Gen. Virol. 80:1079-1085.
3. Arispe, N., and M. Doh. 2002. Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AbetaP (1-40) and (1-42) peptides. FASEB J. 16:1526-1536.
4. Barenholz, Y. 2004. Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications. Subcell. Biochem. 37: 167-215.
5. Bate, C., M. Salmona, L. Diomede, and A. Williams. 2004. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J. Biol. Chem. 279:14983-14990.
6. Bendheim, P. E., H. R. Brown, R. D. Rudelli, L. J. Scala, N. L. Goller, G. Y. Wen, R. J. Kascsak, N. R. Cashman, and D. C. Bolton. 1992. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42:149-156.
7. Boussif, O., F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92:7297-7301.
8. Brown, D. A., and E. London. 1997. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240:1-7.
9. Brown, D. A., and J. K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533-544.
10. Camilleri, P., N. J. Haskins, and D. R. Hewlett. 1994. Beta-cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide. FEBS Lett. 341:256-258.
11. Caughey, B., D. Ernst, and R. E. Race. 1993. Congo red inhibition of scrapie agent replication. J. Virol. 67:6270-6272.
12. Caughey, B., and R. E. Race. 1992. Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 59:768-771.
13. Caughey, B., and G. J. Raymond. 1991. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266:18217-18223.
14. Caughey, W. S., L. D. Raymond, M. Horiuchi, and B. Caughey. 1998. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc. Natl. Acad. Sci. USA 95:12117-12122.
15. Cerneus, D. P., E. Uefling, G. Posthuma, G. J. Strous, and A. van der Ende. 1993. Detergent insolubility of alkaline phosphatase during biosynthetic transport and endocytosis. Role of cholesterol. J. Biol. Chem. 268:3150-3155.
16. Christian, A. E., M. P. Haynes, M. C. Phillips, and G. H. Rothblat. 1997. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38:2264-2272.
17. Cohen, F. E., and S. B. Prusiner. 1998. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67:793-819.
18. Davis, M. E., and M. E. Brewster. 2004. Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3:1023-1035.
19. Gilch, S., K. F. Winklhofer, M. H. Groschup, M. Nunziante, R. Lucassen, C. Spielhaupter, W. Muranyi, D. Riesner, J. Tatzelt, and H. M. Schatzl. 2001. Intracellular re-routing of prion protein prevents propagation of PrP(Sc) and delays onset of prion disease. EMBO J. 20:3957-3966.
20. Haensler, J., and F. C. Szoka, Jr. 1993. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4:372-379.
21. Ishimura, K., K. Fukunaga, T. Irie, K. Uekama, T. Ohta, and H. Nakamura. 1997. Application of a beta-cyclodextrin sulfate-immobilized precolumn to selective on-line enrichment and separation of heparin-binding proteins by column-switching high-performance liquid chromatography. J. Chromatogr. 769:209-214.
22. Kaneko, K., M. Vey, M. Scott, S. Pilkuhn, F. E. Cohen, and S. B. Prusiner. 1997. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc. Natl. Acad. Sci. USA 94:2333-2338.
23. Kolesnick, R. 2002. The therapeutic potential of modulating the ceramide/ sphingomyelin pathway. J. Clin. Investig. 110:3-8.
24. Ladogana, A., P. Casaccia, L. Ingrosso, M. Cibati, M. Salvatore, Y. G. Xi, C. Masullo, and M. Pocchiari. 1992. Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J. Gen. Virol. 73:661-665.
25. Ledesma, M. D., K. Simons, and C. G. Dotti. 1998. Neuronal polarity: essential role of protein-lipid complexes in axonal sorting. Proc. Natl. Acad. Sci. USA 95:3966-3971.
26. Leventis, R., and J. R. Silvius. 2001. Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys. J. 81:2257-2267.
27. Li, R., T. Liu, B. S. Wong, T. Pan, M. Morillas, W. Swietnicki, K. O'Rourke, P. Gambetti, W. K. Surewicz, and M. S. Sy. 2000. Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J. Mol. Biol. 301:567-573.
28. Mahfoud, R., N. Garmy, M. Maresca, N. Yahi, A. Puigserver, and J. Fantini. 2002. Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J. Biol. Chem. 277:11292-11296.
29. Mangé, A., N. Nishida, O. Milhavet, H. E. McMahon, D. Casanova, and S. Lehmann. 2000. Amphotericin B inhibits the generation of the scrapie isoform of the prion protein in infected cultures. J. Virol. 74:3135-3140.
30. May, B. C., A. T. Fafarman, S. B. Hong, M. Rogers, L. W. Deady, S. B. Prusiner, and F. E. Cohen. 2003. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc. Natl. Acad. Sci. USA 100:3416-3421.
31. Meyer, R. K., M. P. McKinley, K. A. Bowman, M. B. Braunfeld, R. A. Barry, and S. B. Prusiner. 1986. Separation and properties of cellular and scrapie prion proteins. Proc. Natl. Acad. Sci. USA 83:2310-2314.
32. Mizoguchi, T., T. Edano, and T. Koshi. 2004. A method of direct measurement for the enzymatic determination of cholesteryl esters. J. Lipid Res. 45:396-401.
33. Monnaert, V., S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli, and E. Monflier. 2004. Behavior of alpha-, beta-, and gamma-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier. J. Pharmacol. Exp. Ther. 310:745-751.
34. Mouillet-Richard, S., M. Ermonval, C. Chebassier, J. L. Laplanche, S. Lehmann, J. M. Launay, and O. Kellermann. 2000. Signal transduction through prion protein. Science 289:1925-1928.
35. Müller, W. E., J. L. Laplanche, H. Ushijima, and H. C. Schroder. 2000. Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease. Mech. Ageing Dev. 116:193-218.
36. Müller, W. E., U. Scheffer, S. Perovic, J. Forrest, and H. C. Schroder. 1997. Interaction of prion protein mRNA with CBP35 and other cellular proteins: possible implications for prion replication and age-dependent changes. Arch. Gerontol. Geriatr. 25:41-58.
37. Naslavsky, N., H. Shmeeda, G. Friedlander, A. Yanai, A. H. Futerman, Y. Barenholz, and A. Taraboulos. 1999. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J. Biol. Chem. 274:20763-20771.
38. Naslavsky, N., R. Stein, A. Yanai, G. Friedlander, and A. Taraboulos. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 272:6324-6331.
39. Nishida, N., D. A. Harris, D. Vilette, H. Laude, Y. Frobert, J. Grassi, D. Casanova, O. Milhavet, and S. Lehmann. 2000. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74:320-325.
40. Ohtani, Y., T. Irie, K. Uekama, K. Fukunaga, and J. Pitha. 1989. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186:17-22.
41. Pan, K. M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen, et al. 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-10966.
42. Parkin, E. T., N. T. Watt, A. J. Turner, and N. M. Hooper. 2004. Dual mechanisms for shedding of the cellular prion protein. J. Biol. Chem. 279: 11170-11178.
43. Peretz, D., R. A. Williamson, K. Kaneko, J. Vergara, E. Leclerc, G. Schmitt-Ulms, I. R. Mehlhorn, G. Legname, M. R. Wormald, P. M. Rudd, R. A. Dwek, D. R. Burton, and S. B. Prusiner. 2001. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412:739-743.
44. Perrier, V., K. Kaneko, J. Safar, J. Vergara, P. Tremblay, S. J. DeArmond, F. E. Cohen, S. B. Prusiner, and A. C. Wallace. 2002. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl. Acad. Sci. USA 99:13079-13084.
45. Perrier, V., A. C. Wallace, K. Kaneko, J. Safar, S. B. Prusiner, and F. E. Cohen. 2000. Mimicking dominant negative inhibition of prion replication through structure-based drug design. Proc. Natl. Acad. Sci. USA 97:6073-6078.
46. Pralle, A., P. Keller, E. L. Florin, K. Simons, and J. K. Horber. 2000. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148:997-1008.
47. Priola, S. A., A. Raines, and W. S. Caughey. 2000. Porphyrin and phthalocyanine antiscrapie compounds. Science 287:1503-1506.
48. Prusiner, S. B. 1991. Molecular biology of prion diseases. Science 252:1515-1522.
49. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
50. Qin, X. R., H. Abe, and H. Nakanishi. 2002. NMR and CD studies on the interaction of Alzheimer beta-amyloid peptide (12-28) with beta-cyclodextrin. Biochem. Biophys. Res. Commun. 297:1011-1015.
51. Rothberg, K. G., Y. S. Ying, B. A. Kamen, and R. G. Anderson. 1990. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J. Cell Biol. 111:2931-2938.
52. Safar, J., P. P. Roller, D. C. Gajdusek, and C. J. Gibbs, Jr. 1993. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J. Biol. Chem. 268:20276-20284.
53. Scheiffele, P., M. G. Roth, and K. Simons. 1997. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 16:5501-5508.
54. Schröder, H. C., and W. E. Muller. 2002. Neuroprotective effect of flupirtine in prion disease. Drugs Today 38:49-58.
55. Simons, K., and R. Ehehalt. 2002. Cholesterol, lipid rafts, and disease. J. Clin. Investig. 110:597-603.
56. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell. Biol. 1:31-39.
57. Simons, M., P. Keller, B. De Strooper, K. Beyreuther, C. G. Dotti, and K. Simons. 1998. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. USA 95:6460-6464.
58. Singh, M., R. Sharma, and U. C. Banerjee. 2002. Biotechnological applications of cyclodextrins. Biotechnol. Adv. 20:341-359.
59. Stahl, N., D. R. Borchelt, K. Hsiao, and S. B. Prusiner. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229-240.
60. Supattapone, S., H. O. Nguyen, F. E. Cohen, S. B. Prusiner, and M. R. Scott. 1999. Elimination of prions by branched polyamines and implications for therapeutics. Proc. Natl. Acad. Sci. USA 96:14529-14534.
61. Szejtli, J. 1998. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98:1743-1754.
62. Taraboulos, A., A. J. Raeber, D. R. Borchelt, D. Serban, and S. B. Prusiner. 1992. Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3:851-863.
63. Taraboulos, A., M. Scott, A. Semenov, D. Avrahami, L. Laszlo, and S. B. Prusiner. 1995. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129:121-132.
64. Taylor, D. R., and N. M. Hooper. 2006. The prion protein and lipid rafts. Mol. Membr. Biol. 23:89-99.
65. Trojanowski, J. Q., and V. M. Lee. 2000. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. N. Y. Acad. Sci. 924:62-67.
66. Uekama, K. 2004. Design and evaluation of cyclodextrin-based drug formulation. Chem. Pharm. Bull. (Tokyo) 52:900-915.
67. Uekama, K., F. Hirayama, and T. Irie. 1998. Cyclodextrin drug carrier systems. Chem. Rev. 98:2045-2076.
68. Vey, M., S. Pilkuhn, H. Wille, R. Nixon, S. J. DeArmond, E. J. Smart, R. G. Anderson, A. Taraboulos, and S. B. Prusiner. 1996. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc. Natl. Acad. Sci. USA 93:14945-14949.